Showing results (491-500 of 533) with videos related to

Sort By:
Pageof 54
Journal of Evolutionary Biology|August 29, 2024
The paradox of predictability provides a bridge between micro- and macroevolutionMasahito Tsuboi, Jacqueline Sztepanacz, Stephen De Lisle, et al.
NPJ Vaccines|June 8, 2024
Differential long-term bivalent HPV vaccine cross-protection by variants in the Costa Rica HPV vaccine trialJaimie Z Shing, Carolina Porras, Maísa Pinheiro, et al.
Scientific Reports|December 9, 2021
Characterization of the humoral immune response to the EBV proteome in extranodal NK/T-cell lymphomaZhiwei Liu, Yomani D Sarathkumara, John K C Chan, et al.
JAMA|March 3, 2011
Nitric oxide for inhalation in the acute treatment of sickle cell pain crisis: a randomized controlled trialMark T Gladwin, Gregory J Kato, Debra Weiner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2024
Impact of an Epstein-Barr Virus Serology-Based Screening Program on Nasopharyngeal Carcinoma Mortality: A Cluster-Randomized Controlled TrialWen-Jie Chen, Xia Yu, Yu-Qiang Lu, et al.
Carcinogenesis|October 3, 2017
Occupational exposure to diesel engine exhaust and alterations in immune/inflammatory markers: a cross-sectional molecular epidemiology study in ChinaBryan A Bassig, Yufei Dai, Roel Vermeulen, et al.
Plos One|July 3, 2014
Risk factors for death in 632 patients with sickle cell disease in the United States and United KingdomMark T Gladwin, Robyn J Barst, J Simon R Gibbs, et al.
Vaccine|July 14, 2024
Meeting report: Considerations for trial design and endpoints in licensing therapeutic HPV16/18 vaccines to prevent cervical cancerPeter M Dull, Sharon L Achilles, Rafi Ahmed, et al.
Cell Reports. Medicine|May 17, 2023
Preclinical characterization of the Toll-like receptor 7/8 antagonist MHV370 for lupus therapyStuart Hawtin, Cédric André, Géraldine Collignon-Zipfel, et al.
Cancer Medicine|January 12, 2020
Cigarette smoking increases the risk of nasopharyngeal carcinoma through the elevated level of IgA antibody against Epstein-Barr virus capsid antigen: A mediation analysisWan-Lun Hsu, Yin-Chu Chien, Yen-Tsung Huang, et al.
Pageof 54